0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Breath Molecular Diagnosis Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-29Z14276
Home | Market Reports | Health| Medical Devices & Equipment
Global Breath Molecular Diagnosis Market Research Report 2023
BUY CHAPTERS

Global Breath Molecular Diagnosis Market Research Report 2025

Code: QYRE-Auto-29Z14276
Report
March 2025
Pages:100
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Breath Molecular Diagnosis Market Size

The global market for Breath Molecular Diagnosis was valued at US$ 263 million in the year 2024 and is projected to reach a revised size of US$ 566 million by 2031, growing at a CAGR of 11.7% during the forecast period.

Breath Molecular Diagnosis Market

Breath Molecular Diagnosis Market

Exhaled breath molecular diagnosis is an emerging in vitro diagnostic (IVD) technology. Generally speaking, in vitro diagnosis requires the use of diagnostic reagents and equipment to analyze samples such as blood or urine. Sampling is done first and then analysis is done. Cells, microorganisms and biochemical molecules can be analyzed. It is mainly used for the diagnosis of blood circulation or systemic diseases. Exhaled breath molecular diagnosis does not require diagnostic reagents, and sampling and analysis can be performed at the same time. The gas molecules produced by cell and microbial metabolism are analyzed, which is particularly suitable for the diagnosis of respiratory and digestive diseases. Exhaled breath molecular diagnosis complements blood tests and imaging diagnosis. Like existing in vitro diagnosis, exhaled breath molecular diagnosis is also divided into two categories: professional laboratories and point-of-care diagnosis (POCT). Professional laboratories use laboratory analysis equipment such as gas chromatography, mass spectrometry and spectroscopy to perform exhaled breath analysis on patients' exhaled gas sampling bags or gas sampling tubes; due to the lack of exhaled breath sensor products, Europe and the United States currently provide analytical services for exhaled metabolomics of H2, CH4 and VOC (volatile organic compounds) through professional laboratories. Point-of-care diagnosis (POCT) uses exhaled breath detection sensors, which integrate sampling and analysis. It only takes a few seconds for patients to sample their exhaled breath, and only tens of seconds for the instrument to analyze the results.
Exhaled breath molecular diagnostic equipment is classified as a low-risk medical device by European and American drug regulatory authorities. The US FDA believes that breath testing will affect the results of medical diagnosis. As a Class II medical device, it only tests and certifies the performance of breath testing. The EU regulates it as a special Class I medical device similar to a sphygmomanometer. It only needs to be tested by itself or by a third-party laboratory according to the EN standard. Therefore, exhaled breath molecular diagnostic equipment was first listed in Europe, and there are a large number of them now. China currently regulates exhaled breath molecular diagnostic equipment as a Class II medical device, and it takes a long time to register. At present, most medical devices related to exhaled breath molecular diagnostic technology are in the market cultivation or introduction stage, requiring a large number of clinical trials, certification and registration.
POCT based on exhaled breath molecular diagnosis can provide detection items that blood test POCT lacks, such as detection of airway inflammation and gastrointestinal flora metabolic disorders. Moreover, POCT based on exhaled breath molecular diagnosis does not require blood drawing, and has the characteristics of non-invasive, instant, and biopsy. It can be used to make up for the shortcomings of in vitro diagnosis such as blood tests and imaging, avoid the risks of invasive in vivo diagnosis, and is more suitable for the use of common diseases and chronic diseases in hospitals, grassroots physical examinations, and family self-examination. In recent years, exhaled breath molecular diagnosis technology has been increasingly valued by domestic and foreign governments, research and development institutions, and related medical organizations. Various organizations and institutions have formulated relevant policies, development plans, and standard guidelines to jointly promote the rapid development of clinical technology for exhaled breath molecular diagnosis.
Exhaled breath molecular diagnosis or breath testing belongs to the emerging field of POCT technology. At present, the Helicobacter pylori breath test with the largest market size has a market history of less than 25 years, and the development of the inflammatory breath test product with the greatest market potential has only been 10 years, while breath testing technologies such as gastrointestinal flora metabolic disorders are still in the market cultivation stage. In addition, breath detection technologies such as breath NH3, H2S, VOC (volatile organic compounds), breath metabolomics and olfactory artificial intelligence (electronic nose) are still in clinical trials or waiting for drug regulatory certification and approval.
In the past 30 years, with the gradual development of related technologies including breath detection abroad, the rapid growth of the domestic economy and the continuous development of the medical and health industry have provided a broad market space for the widespread application of this technology in China. At the same time, the development of domestic breath detection technology is almost synchronized with that of foreign countries, covering almost all areas of foreign breath detection, including the research of breath metabolomics and olfactory artificial intelligence, and many technologies are even ahead of foreign countries. It is one of the few emerging technology fields that may form a global leading breath detection in China.
With the continuous advancement of the construction of the PCCM system, the demand for breath analysis products in secondary and tertiary hospitals will further expand. Portable instrument products, handheld instrument products and other products for primary hospitals and home terminals are constantly being developed, and product application scenarios and usage needs will be further expanded.
With the development of science and technology and artificial intelligence, future breathalyzers will be more intelligent and automated, with functions such as automatic identification, data analysis and report generation, reducing human intervention and improving diagnostic accuracy and efficiency.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Breath Molecular Diagnosis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Breath Molecular Diagnosis.
The Breath Molecular Diagnosis market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Breath Molecular Diagnosis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Breath Molecular Diagnosis manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Breath Molecular Diagnosis Market Report

Report Metric Details
Report Name Breath Molecular Diagnosis Market
Accounted market size in year US$ 263 million
Forecasted market size in 2031 US$ 566 million
CAGR 11.7%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • C13 Type
  • NO Type
  • H2/CO Type
  • VOCs Type
Segment by Application
  • Hospital
  • Clinic
  • Physical Examination Center
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company NIOX Group plc, Headway, Sunvou Medical Electronics Co, Richen Holding, Meridian Bioscience, CAPNIA, Inc., Kibion​​, Otsuka Electronics, LEYI BIOLOGY, Eco Physics AG, Shenzhen Breax, QUINTRON, Beijing Wanliandaxinke Instruments Co, SIMES SIKMA, Beijing Safe Heart Technology, e-LinkCare Meditech Co, ChromX Health, Huiyuen Tech
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Breath Molecular Diagnosis manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Breath Molecular Diagnosis in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Breath Molecular Diagnosis Market growing?

Ans: The Breath Molecular Diagnosis Market witnessing a CAGR of 11.7% during the forecast period 2025-2031.

What is the Breath Molecular Diagnosis Market size in 2031?

Ans: The Breath Molecular Diagnosis Market size in 2031 will be US$ 566 million.

Who are the main players in the Breath Molecular Diagnosis Market report?

Ans: The main players in the Breath Molecular Diagnosis Market are NIOX Group plc, Headway, Sunvou Medical Electronics Co, Richen Holding, Meridian Bioscience, CAPNIA, Inc., Kibion​​, Otsuka Electronics, LEYI BIOLOGY, Eco Physics AG, Shenzhen Breax, QUINTRON, Beijing Wanliandaxinke Instruments Co, SIMES SIKMA, Beijing Safe Heart Technology, e-LinkCare Meditech Co, ChromX Health, Huiyuen Tech

What are the Application segmentation covered in the Breath Molecular Diagnosis Market report?

Ans: The Applications covered in the Breath Molecular Diagnosis Market report are Hospital, Clinic, Physical Examination Center, Other

What are the Type segmentation covered in the Breath Molecular Diagnosis Market report?

Ans: The Types covered in the Breath Molecular Diagnosis Market report are C13 Type, NO Type, H2/CO Type, VOCs Type

Recommended Reports

Breath Diagnostics

Molecular Diagnostics

In Vitro & Blood Gas

1 Breath Molecular Diagnosis Market Overview
1.1 Product Definition
1.2 Breath Molecular Diagnosis by Type
1.2.1 Global Breath Molecular Diagnosis Market Value Comparison by Type (2024 VS 2031)
1.2.2 C13 Type
1.2.3 NO Type
1.2.4 H2/CO Type
1.2.5 VOCs Type
1.3 Breath Molecular Diagnosis by Application
1.3.1 Global Breath Molecular Diagnosis Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Physical Examination Center
1.3.5 Other
1.4 Global Breath Molecular Diagnosis Market Size Estimates and Forecasts
1.4.1 Global Breath Molecular Diagnosis Revenue 2020-2031
1.4.2 Global Breath Molecular Diagnosis Sales 2020-2031
1.4.3 Global Breath Molecular Diagnosis Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Breath Molecular Diagnosis Market Competition by Manufacturers
2.1 Global Breath Molecular Diagnosis Sales Market Share by Manufacturers (2020-2025)
2.2 Global Breath Molecular Diagnosis Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Breath Molecular Diagnosis Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Breath Molecular Diagnosis, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Breath Molecular Diagnosis, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Breath Molecular Diagnosis, Product Type & Application
2.7 Global Key Manufacturers of Breath Molecular Diagnosis, Date of Enter into This Industry
2.8 Global Breath Molecular Diagnosis Market Competitive Situation and Trends
2.8.1 Global Breath Molecular Diagnosis Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Breath Molecular Diagnosis Players Market Share by Revenue
2.8.3 Global Breath Molecular Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Breath Molecular Diagnosis Market Scenario by Region
3.1 Global Breath Molecular Diagnosis Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Breath Molecular Diagnosis Sales by Region: 2020-2031
3.2.1 Global Breath Molecular Diagnosis Sales by Region: 2020-2025
3.2.2 Global Breath Molecular Diagnosis Sales by Region: 2026-2031
3.3 Global Breath Molecular Diagnosis Revenue by Region: 2020-2031
3.3.1 Global Breath Molecular Diagnosis Revenue by Region: 2020-2025
3.3.2 Global Breath Molecular Diagnosis Revenue by Region: 2026-2031
3.4 North America Breath Molecular Diagnosis Market Facts & Figures by Country
3.4.1 North America Breath Molecular Diagnosis Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Breath Molecular Diagnosis Sales by Country (2020-2031)
3.4.3 North America Breath Molecular Diagnosis Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Breath Molecular Diagnosis Market Facts & Figures by Country
3.5.1 Europe Breath Molecular Diagnosis Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Breath Molecular Diagnosis Sales by Country (2020-2031)
3.5.3 Europe Breath Molecular Diagnosis Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Breath Molecular Diagnosis Market Facts & Figures by Region
3.6.1 Asia Pacific Breath Molecular Diagnosis Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Breath Molecular Diagnosis Sales by Region (2020-2031)
3.6.3 Asia Pacific Breath Molecular Diagnosis Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Breath Molecular Diagnosis Market Facts & Figures by Country
3.7.1 Latin America Breath Molecular Diagnosis Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Breath Molecular Diagnosis Sales by Country (2020-2031)
3.7.3 Latin America Breath Molecular Diagnosis Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Breath Molecular Diagnosis Market Facts & Figures by Country
3.8.1 Middle East and Africa Breath Molecular Diagnosis Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Breath Molecular Diagnosis Sales by Country (2020-2031)
3.8.3 Middle East and Africa Breath Molecular Diagnosis Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Breath Molecular Diagnosis Sales by Type (2020-2031)
4.1.1 Global Breath Molecular Diagnosis Sales by Type (2020-2025)
4.1.2 Global Breath Molecular Diagnosis Sales by Type (2026-2031)
4.1.3 Global Breath Molecular Diagnosis Sales Market Share by Type (2020-2031)
4.2 Global Breath Molecular Diagnosis Revenue by Type (2020-2031)
4.2.1 Global Breath Molecular Diagnosis Revenue by Type (2020-2025)
4.2.2 Global Breath Molecular Diagnosis Revenue by Type (2026-2031)
4.2.3 Global Breath Molecular Diagnosis Revenue Market Share by Type (2020-2031)
4.3 Global Breath Molecular Diagnosis Price by Type (2020-2031)
5 Segment by Application
5.1 Global Breath Molecular Diagnosis Sales by Application (2020-2031)
5.1.1 Global Breath Molecular Diagnosis Sales by Application (2020-2025)
5.1.2 Global Breath Molecular Diagnosis Sales by Application (2026-2031)
5.1.3 Global Breath Molecular Diagnosis Sales Market Share by Application (2020-2031)
5.2 Global Breath Molecular Diagnosis Revenue by Application (2020-2031)
5.2.1 Global Breath Molecular Diagnosis Revenue by Application (2020-2025)
5.2.2 Global Breath Molecular Diagnosis Revenue by Application (2026-2031)
5.2.3 Global Breath Molecular Diagnosis Revenue Market Share by Application (2020-2031)
5.3 Global Breath Molecular Diagnosis Price by Application (2020-2031)
6 Key Companies Profiled
6.1 NIOX Group plc
6.1.1 NIOX Group plc Company Information
6.1.2 NIOX Group plc Description and Business Overview
6.1.3 NIOX Group plc Breath Molecular Diagnosis Sales, Revenue and Gross Margin (2020-2025)
6.1.4 NIOX Group plc Breath Molecular Diagnosis Product Portfolio
6.1.5 NIOX Group plc Recent Developments/Updates
6.2 Headway
6.2.1 Headway Company Information
6.2.2 Headway Description and Business Overview
6.2.3 Headway Breath Molecular Diagnosis Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Headway Breath Molecular Diagnosis Product Portfolio
6.2.5 Headway Recent Developments/Updates
6.3 Sunvou Medical Electronics Co
6.3.1 Sunvou Medical Electronics Co Company Information
6.3.2 Sunvou Medical Electronics Co Description and Business Overview
6.3.3 Sunvou Medical Electronics Co Breath Molecular Diagnosis Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Sunvou Medical Electronics Co Breath Molecular Diagnosis Product Portfolio
6.3.5 Sunvou Medical Electronics Co Recent Developments/Updates
6.4 Richen Holding
6.4.1 Richen Holding Company Information
6.4.2 Richen Holding Description and Business Overview
6.4.3 Richen Holding Breath Molecular Diagnosis Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Richen Holding Breath Molecular Diagnosis Product Portfolio
6.4.5 Richen Holding Recent Developments/Updates
6.5 Meridian Bioscience
6.5.1 Meridian Bioscience Company Information
6.5.2 Meridian Bioscience Description and Business Overview
6.5.3 Meridian Bioscience Breath Molecular Diagnosis Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Meridian Bioscience Breath Molecular Diagnosis Product Portfolio
6.5.5 Meridian Bioscience Recent Developments/Updates
6.6 CAPNIA, Inc.
6.6.1 CAPNIA, Inc. Company Information
6.6.2 CAPNIA, Inc. Description and Business Overview
6.6.3 CAPNIA, Inc. Breath Molecular Diagnosis Sales, Revenue and Gross Margin (2020-2025)
6.6.4 CAPNIA, Inc. Breath Molecular Diagnosis Product Portfolio
6.6.5 CAPNIA, Inc. Recent Developments/Updates
6.7 Kibion​​
6.7.1 Kibion​​ Company Information
6.7.2 Kibion​​ Description and Business Overview
6.7.3 Kibion​​ Breath Molecular Diagnosis Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Kibion​​ Breath Molecular Diagnosis Product Portfolio
6.7.5 Kibion​​ Recent Developments/Updates
6.8 Otsuka Electronics
6.8.1 Otsuka Electronics Company Information
6.8.2 Otsuka Electronics Description and Business Overview
6.8.3 Otsuka Electronics Breath Molecular Diagnosis Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Otsuka Electronics Breath Molecular Diagnosis Product Portfolio
6.8.5 Otsuka Electronics Recent Developments/Updates
6.9 LEYI BIOLOGY
6.9.1 LEYI BIOLOGY Company Information
6.9.2 LEYI BIOLOGY Description and Business Overview
6.9.3 LEYI BIOLOGY Breath Molecular Diagnosis Sales, Revenue and Gross Margin (2020-2025)
6.9.4 LEYI BIOLOGY Breath Molecular Diagnosis Product Portfolio
6.9.5 LEYI BIOLOGY Recent Developments/Updates
6.10 Eco Physics AG
6.10.1 Eco Physics AG Company Information
6.10.2 Eco Physics AG Description and Business Overview
6.10.3 Eco Physics AG Breath Molecular Diagnosis Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Eco Physics AG Breath Molecular Diagnosis Product Portfolio
6.10.5 Eco Physics AG Recent Developments/Updates
6.11 Shenzhen Breax
6.11.1 Shenzhen Breax Company Information
6.11.2 Shenzhen Breax Description and Business Overview
6.11.3 Shenzhen Breax Breath Molecular Diagnosis Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Shenzhen Breax Breath Molecular Diagnosis Product Portfolio
6.11.5 Shenzhen Breax Recent Developments/Updates
6.12 QUINTRON
6.12.1 QUINTRON Company Information
6.12.2 QUINTRON Description and Business Overview
6.12.3 QUINTRON Breath Molecular Diagnosis Sales, Revenue and Gross Margin (2020-2025)
6.12.4 QUINTRON Breath Molecular Diagnosis Product Portfolio
6.12.5 QUINTRON Recent Developments/Updates
6.13 Beijing Wanliandaxinke Instruments Co
6.13.1 Beijing Wanliandaxinke Instruments Co Company Information
6.13.2 Beijing Wanliandaxinke Instruments Co Description and Business Overview
6.13.3 Beijing Wanliandaxinke Instruments Co Breath Molecular Diagnosis Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Beijing Wanliandaxinke Instruments Co Breath Molecular Diagnosis Product Portfolio
6.13.5 Beijing Wanliandaxinke Instruments Co Recent Developments/Updates
6.14 SIMES SIKMA
6.14.1 SIMES SIKMA Company Information
6.14.2 SIMES SIKMA Description and Business Overview
6.14.3 SIMES SIKMA Breath Molecular Diagnosis Sales, Revenue and Gross Margin (2020-2025)
6.14.4 SIMES SIKMA Breath Molecular Diagnosis Product Portfolio
6.14.5 SIMES SIKMA Recent Developments/Updates
6.15 Beijing Safe Heart Technology
6.15.1 Beijing Safe Heart Technology Company Information
6.15.2 Beijing Safe Heart Technology Description and Business Overview
6.15.3 Beijing Safe Heart Technology Breath Molecular Diagnosis Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Beijing Safe Heart Technology Breath Molecular Diagnosis Product Portfolio
6.15.5 Beijing Safe Heart Technology Recent Developments/Updates
6.16 e-LinkCare Meditech Co
6.16.1 e-LinkCare Meditech Co Company Information
6.16.2 e-LinkCare Meditech Co Description and Business Overview
6.16.3 e-LinkCare Meditech Co Breath Molecular Diagnosis Sales, Revenue and Gross Margin (2020-2025)
6.16.4 e-LinkCare Meditech Co Breath Molecular Diagnosis Product Portfolio
6.16.5 e-LinkCare Meditech Co Recent Developments/Updates
6.17 ChromX Health
6.17.1 ChromX Health Company Information
6.17.2 ChromX Health Description and Business Overview
6.17.3 ChromX Health Breath Molecular Diagnosis Sales, Revenue and Gross Margin (2020-2025)
6.17.4 ChromX Health Breath Molecular Diagnosis Product Portfolio
6.17.5 ChromX Health Recent Developments/Updates
6.18 Huiyuen Tech
6.18.1 Huiyuen Tech Company Information
6.18.2 Huiyuen Tech Description and Business Overview
6.18.3 Huiyuen Tech Breath Molecular Diagnosis Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Huiyuen Tech Breath Molecular Diagnosis Product Portfolio
6.18.5 Huiyuen Tech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Breath Molecular Diagnosis Industry Chain Analysis
7.2 Breath Molecular Diagnosis Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Breath Molecular Diagnosis Production Mode & Process Analysis
7.4 Breath Molecular Diagnosis Sales and Marketing
7.4.1 Breath Molecular Diagnosis Sales Channels
7.4.2 Breath Molecular Diagnosis Distributors
7.5 Breath Molecular Diagnosis Customer Analysis
8 Breath Molecular Diagnosis Market Dynamics
8.1 Breath Molecular Diagnosis Industry Trends
8.2 Breath Molecular Diagnosis Market Drivers
8.3 Breath Molecular Diagnosis Market Challenges
8.4 Breath Molecular Diagnosis Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Breath Molecular Diagnosis Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Breath Molecular Diagnosis Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Breath Molecular Diagnosis Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Breath Molecular Diagnosis Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Breath Molecular Diagnosis Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Breath Molecular Diagnosis Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Breath Molecular Diagnosis Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Breath Molecular Diagnosis Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Breath Molecular Diagnosis, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Breath Molecular Diagnosis, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Breath Molecular Diagnosis, Product Type & Application
 Table 12. Global Key Manufacturers of Breath Molecular Diagnosis, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Breath Molecular Diagnosis by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Breath Molecular Diagnosis as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Breath Molecular Diagnosis Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Breath Molecular Diagnosis Sales by Region (2020-2025) & (K Units)
 Table 18. Global Breath Molecular Diagnosis Sales Market Share by Region (2020-2025)
 Table 19. Global Breath Molecular Diagnosis Sales by Region (2026-2031) & (K Units)
 Table 20. Global Breath Molecular Diagnosis Sales Market Share by Region (2026-2031)
 Table 21. Global Breath Molecular Diagnosis Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Breath Molecular Diagnosis Revenue Market Share by Region (2020-2025)
 Table 23. Global Breath Molecular Diagnosis Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Breath Molecular Diagnosis Revenue Market Share by Region (2026-2031)
 Table 25. North America Breath Molecular Diagnosis Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Breath Molecular Diagnosis Sales by Country (2020-2025) & (K Units)
 Table 27. North America Breath Molecular Diagnosis Sales by Country (2026-2031) & (K Units)
 Table 28. North America Breath Molecular Diagnosis Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Breath Molecular Diagnosis Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Breath Molecular Diagnosis Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Breath Molecular Diagnosis Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Breath Molecular Diagnosis Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Breath Molecular Diagnosis Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Breath Molecular Diagnosis Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Breath Molecular Diagnosis Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Breath Molecular Diagnosis Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Breath Molecular Diagnosis Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Breath Molecular Diagnosis Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Breath Molecular Diagnosis Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Breath Molecular Diagnosis Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Breath Molecular Diagnosis Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Breath Molecular Diagnosis Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Breath Molecular Diagnosis Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Breath Molecular Diagnosis Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Breath Molecular Diagnosis Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Breath Molecular Diagnosis Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Breath Molecular Diagnosis Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Breath Molecular Diagnosis Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Breath Molecular Diagnosis Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Breath Molecular Diagnosis Sales (K Units) by Type (2020-2025)
 Table 51. Global Breath Molecular Diagnosis Sales (K Units) by Type (2026-2031)
 Table 52. Global Breath Molecular Diagnosis Sales Market Share by Type (2020-2025)
 Table 53. Global Breath Molecular Diagnosis Sales Market Share by Type (2026-2031)
 Table 54. Global Breath Molecular Diagnosis Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Breath Molecular Diagnosis Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Breath Molecular Diagnosis Revenue Market Share by Type (2020-2025)
 Table 57. Global Breath Molecular Diagnosis Revenue Market Share by Type (2026-2031)
 Table 58. Global Breath Molecular Diagnosis Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Breath Molecular Diagnosis Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Breath Molecular Diagnosis Sales (K Units) by Application (2020-2025)
 Table 61. Global Breath Molecular Diagnosis Sales (K Units) by Application (2026-2031)
 Table 62. Global Breath Molecular Diagnosis Sales Market Share by Application (2020-2025)
 Table 63. Global Breath Molecular Diagnosis Sales Market Share by Application (2026-2031)
 Table 64. Global Breath Molecular Diagnosis Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Breath Molecular Diagnosis Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Breath Molecular Diagnosis Revenue Market Share by Application (2020-2025)
 Table 67. Global Breath Molecular Diagnosis Revenue Market Share by Application (2026-2031)
 Table 68. Global Breath Molecular Diagnosis Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Breath Molecular Diagnosis Price (US$/Unit) by Application (2026-2031)
 Table 70. NIOX Group plc Company Information
 Table 71. NIOX Group plc Description and Business Overview
 Table 72. NIOX Group plc Breath Molecular Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. NIOX Group plc Breath Molecular Diagnosis Product
 Table 74. NIOX Group plc Recent Developments/Updates
 Table 75. Headway Company Information
 Table 76. Headway Description and Business Overview
 Table 77. Headway Breath Molecular Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Headway Breath Molecular Diagnosis Product
 Table 79. Headway Recent Developments/Updates
 Table 80. Sunvou Medical Electronics Co Company Information
 Table 81. Sunvou Medical Electronics Co Description and Business Overview
 Table 82. Sunvou Medical Electronics Co Breath Molecular Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Sunvou Medical Electronics Co Breath Molecular Diagnosis Product
 Table 84. Sunvou Medical Electronics Co Recent Developments/Updates
 Table 85. Richen Holding Company Information
 Table 86. Richen Holding Description and Business Overview
 Table 87. Richen Holding Breath Molecular Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Richen Holding Breath Molecular Diagnosis Product
 Table 89. Richen Holding Recent Developments/Updates
 Table 90. Meridian Bioscience Company Information
 Table 91. Meridian Bioscience Description and Business Overview
 Table 92. Meridian Bioscience Breath Molecular Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Meridian Bioscience Breath Molecular Diagnosis Product
 Table 94. Meridian Bioscience Recent Developments/Updates
 Table 95. CAPNIA, Inc. Company Information
 Table 96. CAPNIA, Inc. Description and Business Overview
 Table 97. CAPNIA, Inc. Breath Molecular Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. CAPNIA, Inc. Breath Molecular Diagnosis Product
 Table 99. CAPNIA, Inc. Recent Developments/Updates
 Table 100. Kibion​​ Company Information
 Table 101. Kibion​​ Description and Business Overview
 Table 102. Kibion​​ Breath Molecular Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Kibion​​ Breath Molecular Diagnosis Product
 Table 104. Kibion​​ Recent Developments/Updates
 Table 105. Otsuka Electronics Company Information
 Table 106. Otsuka Electronics Description and Business Overview
 Table 107. Otsuka Electronics Breath Molecular Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Otsuka Electronics Breath Molecular Diagnosis Product
 Table 109. Otsuka Electronics Recent Developments/Updates
 Table 110. LEYI BIOLOGY Company Information
 Table 111. LEYI BIOLOGY Description and Business Overview
 Table 112. LEYI BIOLOGY Breath Molecular Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. LEYI BIOLOGY Breath Molecular Diagnosis Product
 Table 114. LEYI BIOLOGY Recent Developments/Updates
 Table 115. Eco Physics AG Company Information
 Table 116. Eco Physics AG Description and Business Overview
 Table 117. Eco Physics AG Breath Molecular Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Eco Physics AG Breath Molecular Diagnosis Product
 Table 119. Eco Physics AG Recent Developments/Updates
 Table 120. Shenzhen Breax Company Information
 Table 121. Shenzhen Breax Description and Business Overview
 Table 122. Shenzhen Breax Breath Molecular Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Shenzhen Breax Breath Molecular Diagnosis Product
 Table 124. Shenzhen Breax Recent Developments/Updates
 Table 125. QUINTRON Company Information
 Table 126. QUINTRON Description and Business Overview
 Table 127. QUINTRON Breath Molecular Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. QUINTRON Breath Molecular Diagnosis Product
 Table 129. QUINTRON Recent Developments/Updates
 Table 130. Beijing Wanliandaxinke Instruments Co Company Information
 Table 131. Beijing Wanliandaxinke Instruments Co Description and Business Overview
 Table 132. Beijing Wanliandaxinke Instruments Co Breath Molecular Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Beijing Wanliandaxinke Instruments Co Breath Molecular Diagnosis Product
 Table 134. Beijing Wanliandaxinke Instruments Co Recent Developments/Updates
 Table 135. SIMES SIKMA Company Information
 Table 136. SIMES SIKMA Description and Business Overview
 Table 137. SIMES SIKMA Breath Molecular Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. SIMES SIKMA Breath Molecular Diagnosis Product
 Table 139. SIMES SIKMA Recent Developments/Updates
 Table 140. Beijing Safe Heart Technology Company Information
 Table 141. Beijing Safe Heart Technology Description and Business Overview
 Table 142. Beijing Safe Heart Technology Breath Molecular Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Beijing Safe Heart Technology Breath Molecular Diagnosis Product
 Table 144. Beijing Safe Heart Technology Recent Developments/Updates
 Table 145. e-LinkCare Meditech Co Company Information
 Table 146. e-LinkCare Meditech Co Description and Business Overview
 Table 147. e-LinkCare Meditech Co Breath Molecular Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. e-LinkCare Meditech Co Breath Molecular Diagnosis Product
 Table 149. e-LinkCare Meditech Co Recent Developments/Updates
 Table 150. ChromX Health Company Information
 Table 151. ChromX Health Description and Business Overview
 Table 152. ChromX Health Breath Molecular Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 153. ChromX Health Breath Molecular Diagnosis Product
 Table 154. ChromX Health Recent Developments/Updates
 Table 155. Huiyuen Tech Company Information
 Table 156. Huiyuen Tech Description and Business Overview
 Table 157. Huiyuen Tech Breath Molecular Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 158. Huiyuen Tech Breath Molecular Diagnosis Product
 Table 159. Huiyuen Tech Recent Developments/Updates
 Table 160. Key Raw Materials Lists
 Table 161. Raw Materials Key Suppliers Lists
 Table 162. Breath Molecular Diagnosis Distributors List
 Table 163. Breath Molecular Diagnosis Customers List
 Table 164. Breath Molecular Diagnosis Market Trends
 Table 165. Breath Molecular Diagnosis Market Drivers
 Table 166. Breath Molecular Diagnosis Market Challenges
 Table 167. Breath Molecular Diagnosis Market Restraints
 Table 168. Research Programs/Design for This Report
 Table 169. Key Data Information from Secondary Sources
 Table 170. Key Data Information from Primary Sources
 Table 171. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Breath Molecular Diagnosis
 Figure 2. Global Breath Molecular Diagnosis Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Breath Molecular Diagnosis Market Share by Type: 2024 & 2031
 Figure 4. C13 Type Product Picture
 Figure 5. NO Type Product Picture
 Figure 6. H2/CO Type Product Picture
 Figure 7. VOCs Type Product Picture
 Figure 8. Global Breath Molecular Diagnosis Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Breath Molecular Diagnosis Market Share by Application: 2024 & 2031
 Figure 10. Hospital
 Figure 11. Clinic
 Figure 12. Physical Examination Center
 Figure 13. Other
 Figure 14. Global Breath Molecular Diagnosis Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Breath Molecular Diagnosis Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Breath Molecular Diagnosis Sales (2020-2031) & (K Units)
 Figure 17. Global Breath Molecular Diagnosis Average Price (US$/Unit) & (2020-2031)
 Figure 18. Breath Molecular Diagnosis Report Years Considered
 Figure 19. Breath Molecular Diagnosis Sales Share by Manufacturers in 2024
 Figure 20. Global Breath Molecular Diagnosis Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest Breath Molecular Diagnosis Players: Market Share by Revenue in Breath Molecular Diagnosis in 2024
 Figure 22. Breath Molecular Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global Breath Molecular Diagnosis Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America Breath Molecular Diagnosis Sales Market Share by Country (2020-2031)
 Figure 25. North America Breath Molecular Diagnosis Revenue Market Share by Country (2020-2031)
 Figure 26. United States Breath Molecular Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada Breath Molecular Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe Breath Molecular Diagnosis Sales Market Share by Country (2020-2031)
 Figure 29. Europe Breath Molecular Diagnosis Revenue Market Share by Country (2020-2031)
 Figure 30. Germany Breath Molecular Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France Breath Molecular Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. Breath Molecular Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy Breath Molecular Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia Breath Molecular Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific Breath Molecular Diagnosis Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific Breath Molecular Diagnosis Revenue Market Share by Region (2020-2031)
 Figure 37. China Breath Molecular Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan Breath Molecular Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea Breath Molecular Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India Breath Molecular Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia Breath Molecular Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. China Taiwan Breath Molecular Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Southeast Asia Breath Molecular Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Breath Molecular Diagnosis Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Breath Molecular Diagnosis Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Breath Molecular Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Breath Molecular Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Breath Molecular Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Breath Molecular Diagnosis Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Breath Molecular Diagnosis Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Breath Molecular Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Breath Molecular Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE Breath Molecular Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Breath Molecular Diagnosis by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Breath Molecular Diagnosis by Type (2020-2031)
 Figure 56. Global Breath Molecular Diagnosis Price (US$/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Breath Molecular Diagnosis by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Breath Molecular Diagnosis by Application (2020-2031)
 Figure 59. Global Breath Molecular Diagnosis Price (US$/Unit) by Application (2020-2031)
 Figure 60. Breath Molecular Diagnosis Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

RELATED REPORTS

Global Surgical Waste Management Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-16G6108
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global PET-CT Scanning Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-27Q5892
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Micromanipulation Pipettes for IVF Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14K19926
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Nebulizer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15N17310
Fri Sep 12 00:00:00 UTC 2025

Add to Cart